• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    More On SPL.AX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Starpharma Holdings Limited (SPL.AX)

    -ASX
    0.52 Up 0.01(0.97%) Dec 23, 10:10PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Starpharma Holdings Limited
    Baker IDI Building
    75 Commercial Road
    Melbourne, VIC 3004
    Australia - Map
    Phone: 61 3 8532 2700
    Fax: 61 3 9510 5955
    Website: http://www.starpharma.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:N/A

    Business Summary 

    Starpharma Holdings Limited researches, develops, and commercializes dendrimer products for pharmaceutical, life-science, and other applications primarily in Australia. The company focuses on the development of VivaGel, a microbicidal agent in Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for prevention of sexual transmitted infections. It also develops dendrimer-enhanced, or DEP versions of existing drugs, including DEP docetaxel in Phase I clinical trial for breast, prostate, lung, and ovarian tumor; and agrochemicals. Starpharma Holdings Limited was founded in 1996 and is headquartered in Melbourne, Australia.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Starpharma Holdings Limited

    Key Executives 
     PayExercised
    Dr. Jacinth K. Fairley B.Sc., B.V.Sc.(Hons), MBA, 51
    Chief Exec. Officer and Exec. Director
    678.00K0.00
    Mr. Nigel J. Baade B.Com, CPA, Grad. Dip. Arts,
    Chief Financial Officer and Company Sec.
    286.00K0.00
    Dr. Jeremy R. Paull BSc (Hons), Ph.D.,
    VP of Devel. & Regulatory Affairs
    266.00K0.00
    Dr. C. Paul Barrett B.Sc. (Hons), Ph.D.,
    VP of Bus. Devel.
    279.00K0.00
    Dr. David J. Owen BSc(Hons) Ph.D.,
    VP of Research
    282.00K0.00
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in AUD.